Growth / Late-Stage Venture Capital

What it is

Growth-stage (also called late-stage venture) covers the financing rounds that take a private company from proven product-market fit through to an IPO or strategic acquisition. PitchBook, the primary data source for US venture activity, defines late-stage venture as Series C and D rounds in companies in a scaling phase, and separately defines "venture growth" as Series E or later, or any round in a company at least seven years old with six or more prior VC rounds. Round sizes at these stages start at roughly US$50 million and routinely exceed US$1 billion.

The investor base is distinct from early-stage venture. It includes dedicated growth funds such as Sequoia Growth (US), General Atlantic (US), and Insight Partners (US); crossover funds that invest across public and private markets, notably Tiger Global (US), Coatue (US), and SoftBank Vision Fund (Japan); sovereign wealth funds including GIC (Singapore), Mubadala (Abu Dhabi), and Ontario Teachers' Pension Plan (Canada); and mutual funds and hedge funds that entered private markets during the 2019-2021 low-rate period.

History

Late-stage private financing as a distinct category coalesced in the mid-2000s as US technology companies began deferring IPOs and required larger pools of private capital to fund growth. SoftBank (Japan) launched its US$100 billion Vision Fund I in 2017, committing capital at a scale that reset global valuation benchmarks and accelerated the formation of the unicorn class, private companies at US$1 billion or higher valuations. Tiger Global and Coatue became the dominant crossover participants from 2019 to 2021, each executing hundreds of late-stage deals per year at elevated prices. The 2021 bubble marked the high-water mark: US venture investment reached roughly US$340 billion for the full year. Rising US Federal Reserve interest rates in 2022 and 2023 repriced growth assets sharply, compressing late-stage valuations 40-70% and clearing many crossover investors from the market. Recovery began in 2024 and accelerated through 2025-26 as AI infrastructure demand generated a new cohort of large rounds.

Current state

Total global startup investment in H1 2026 reached US$510 billion, exceeding the full-year 2025 total of US$440 billion. Late-stage funding in Q2 2026 reached US$134 billion, up 141% from Q2 2025. Sixteen companies raised billion-dollar rounds in Q2 alone, totaling US$108.6 billion, 53% of Q2 funding. Capital concentration is severe: in Q1 2026, removing the five largest deals cut the quarter's total deal value by 73%. AI-focused companies absorbed more than 70% of global Q2 2026 venture investment, up from under 50% a year earlier. Among the rounds tracked in this graph, Ramp's US$750 million Series F at a US$44 billion valuation, Supabase's US$500 million Series F at US$10.5 billion, Kalshi's US$1 billion Series F at US$22 billion, and Skild AI's US$1.4 billion Series C at US$14 billion all closed between January and June 2026. There are roughly 1,590 active unicorns globally as of early 2026.

Relationships

SoftBank Vision Fund (Japan) is the most active single institutional actor at late and growth stage globally, with positions across robotics, AI, and semiconductor platforms. GIC (Singapore) appeared as lead or co-investor in both Supabase and Ramp in H1 2026. Sequoia, Andreessen Horowitz, and Coatue are the most active US-origin growth-stage funds in the current cycle. A structural pressure increasingly visible at this stage is cap table complexity: companies that have raised six or more rounds accumulate layered liquidation preferences, competing investor rights, and divergent time horizons that block or delay exits even when IPO or M&A markets open.

What to watch

SpaceX, OpenAI, Anthropic, Stripe, and Klarna are the most-cited IPO candidates for 2026-27; any single listing would generate the first major liquidity events for the current growth-stage cohort. AI concentration is the central structural exposure: if AI model demand slows or compute economics shift, late-stage valuations in AI infrastructure will face the same repricing dynamic that hit SaaS and consumer tech in 2022-23. Tiger Global and Coatue have remained largely absent from late-stage deal flow since 2022; whether they return, or whether sovereign wealth funds permanently assume their role, will determine whether current multiples hold.